IBDEI1QG ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31025,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Acute
 ;;^UTILITY(U,$J,358.3,31025,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,31025,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,31026,0)
 ;;=E78.0^^190^1931^10
 ;;^UTILITY(U,$J,358.3,31026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31026,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,31026,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,31026,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,31027,0)
 ;;=E78.1^^190^1931^11
 ;;^UTILITY(U,$J,358.3,31027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31027,1,3,0)
 ;;=3^Pure Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,31027,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,31027,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,31028,0)
 ;;=E78.2^^190^1931^9
 ;;^UTILITY(U,$J,358.3,31028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31028,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,31028,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,31028,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,31029,0)
 ;;=I10.^^190^1931^1
 ;;^UTILITY(U,$J,358.3,31029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31029,1,3,0)
 ;;=3^Essential Primary Hypertension
 ;;^UTILITY(U,$J,358.3,31029,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,31029,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,31030,0)
 ;;=I11.9^^190^1931^8
 ;;^UTILITY(U,$J,358.3,31030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31030,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,31030,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,31030,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,31031,0)
 ;;=I11.0^^190^1931^7
 ;;^UTILITY(U,$J,358.3,31031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31031,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,31031,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,31031,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,31032,0)
 ;;=I12.0^^190^1931^6
 ;;^UTILITY(U,$J,358.3,31032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31032,1,3,0)
 ;;=3^Hypertensive Chr Kidney Disease w/ ESRD
 ;;^UTILITY(U,$J,358.3,31032,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,31032,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,31033,0)
 ;;=I13.10^^190^1931^4
 ;;^UTILITY(U,$J,358.3,31033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31033,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,31033,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,31033,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,31034,0)
 ;;=I13.0^^190^1931^2
 ;;^UTILITY(U,$J,358.3,31034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31034,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,31034,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,31034,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,31035,0)
 ;;=I13.11^^190^1931^5
 ;;^UTILITY(U,$J,358.3,31035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31035,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,31035,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,31035,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,31036,0)
 ;;=I13.2^^190^1931^3
 ;;^UTILITY(U,$J,358.3,31036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31036,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,31036,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,31036,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,31037,0)
 ;;=B07.9^^190^1932^289
 ;;^UTILITY(U,$J,358.3,31037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31037,1,3,0)
 ;;=3^Viral Wart,Unspec
 ;;^UTILITY(U,$J,358.3,31037,1,4,0)
 ;;=4^B07.9
 ;;^UTILITY(U,$J,358.3,31037,2)
 ;;=^5000519
 ;;^UTILITY(U,$J,358.3,31038,0)
 ;;=A63.0^^190^1932^34
